Learn more about the efficacy in IC-ineligible patients with newly diagnosed AML
Learn more about
the efficacy in patients
with R/R AML
BOXED WARNING: Patients treated with TIBSOVO have experienced symptoms of differentiation syndrome, which can be fatal if not treated. TIBSOVO is associated with the following Warnings and Precautions: differentiation syndrome, QTc prolongation, and Guillain-Barré syndrome.